HOUSTON, May 25 /PRNewswire-FirstCall/ -- Pediatric Prosthetics Inc. , the national provider of specialized pediatric prosthetics for upper and lower limbs, announced that effective at the open of the market today, the Company has commenced trading on the OTC Bulletin Board. The Company's trading symbol remains PDPR. President Linda Putback-Bean and VP of Operations Kenneth Bean, would like to personally thank all shareholders for their support throughout the listing process and hope they will join them in celebrating this key milestone.
Mr. Bean said, "A move to the OTC Bulletin Board is an important part of our strategy to increase liquidity and transparency for our stock. For those who have been with us from the beginning, we appreciate you and reiterate that we expect great things to come as a result of our new status as a fully reporting company. We look forward to welcoming new investors into the fold, as we increase our reach to retail and institutional investors."
About Pediatric Prosthetics Inc.
Pediatric Prosthetics Inc. is the national provider of specialized pediatric prosthetics for both upper and lower limbs. The Company's CEO Linda Putback-Bean pioneered fitting state-of-the-art myoelectric upper extremity prostheses for the pediatric niche market. In the absence of a hand or arm, a child's brain still continues sending signals to grasp or open the hand in the residual limb. Myoelectric sensors can read those signals through the skin, (requiring no surgery), and with a computer chip can magnify those signals many fold to actuate a tiny powerful motor to accomplish tasks with the life- like hand. In 2003, Ms. Putback-Bean founded Pediatric Prosthetics to create a comprehensive organization that connects parents and their children with a limb loss, to expert pediatric prosthetic fitting, rehabilitation, and life- long care. As a result, Pediatric Prosthetics hopes to increase the quality of life for patients and their families nationwide. For more information, visit http://www.kidscanplay.com.
All interested parties and shareholders are invited to receive the latest news and information about Pediatric Prosthetics by email, to sign-up, visit: http://otcfn.com/pdpr/email_update.html. Additional information for investors may be found online at http://www.otcfn.com/pdpr.
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular when used in the preceding discussion, the words "believes", "expects", "intends", "will", "anticipated" or "may" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Except for historical information, all of the statements expectations and assumptions contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties including, without limitation, risks associated with operations, availability of capital on a reasonable term, the effects of government regulations and operations risks, and the risk factors set forth from time to time in the Company's SEC reports, included but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB, and any reports on Form 8-K. It is possible that the assumptions made by management are not necessarily the most likely and may not materialize. Pediatric Prosthetics Inc. takes no obligation to update or correct forward-looking statements, and also takes no obligation to update or correct information prepared by third parties that is not paid for by the Company. The forward-looking statements contained herein reflect the Company's judgment as of the date of this release, and the Company cautions readers not to place undue reliance on these statements.
Pediatric Prosthetics Inc.
CONTACT: At Pediatric Prosthetics Inc., Kenneth Bean, +1-866-582-0966,email@example.com; or At OTC Financial Network, Geoffrey Eiten,+1-781-444- 6100, ext. 613, firstname.lastname@example.org; Rick McCaffrey,+1-781-444-6100 ext. 625, email@example.com